The Platelet as a Target for Damage

作者: M.-H. Tran

DOI: 10.1016/B978-0-12-386456-7.06207-9

关键词:

摘要: Multiple effectors are involved in reducing platelet survival. These include the spleen, liver, vascular endothelial system, elements of adaptive and innate immune systems, coagulation system. organs circulating factors typically act concert with one another – to varying degrees depending upon etiology pathological removal. Improved understanding molecular mechanisms has led increased recognition complement as an etiologic agent thrombocytopenia, leading new therapeutic possibilities. The activated cell promotes activation enhanced consumption, particularly setting heparin-induced thrombocytopenia where a significant prothrombotic state is promulgated despite thrombocytopenia. In other disorders, cofactors important regulation (atypical hemolytic uremic syndrome) or cleavage ultra large multimers von Willebrand factor (thrombotic thrombocytopenic purpura) reduced absent heightened consumption defects. Depending their specificity, elaboration autoantibodies (immune thrombocytopenia) alloantibodies (human leukocyte antigen alloimmunization, neonatal alloimmune posttransfusion results abnormal clearance. Due presence target antigens on donor platelets, transfusion unselected platelets these circumstances associated poor increments. A basic pathobiology processes may therefore improve diagnostic treatment decisions open doors research.

参考文章(100)
Volker Kiefel, Dirk Bassler, Hartmut Kroll, Bosco Paes, Günter Giers, Juliana Ditomasso, Heidemarie Alber, Monika Berns, Bea Wiebe, Ernst-Markus Quenzel, Jochen Hoch, Andreas Greinacher, Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT) Blood. ,vol. 107, pp. 3761- 3763 ,(2006) , 10.1182/BLOOD-2005-06-2235
Gary Stack, Barton Kenney, Drug-Induced Thrombocytopenia Archives of Pathology & Laboratory Medicine. ,vol. 133, pp. 309- 314 ,(2009) , 10.1043/1543-2165-133.2.309
Julie A. Peterson, Shannon M. Pechauer, Maria L. Gitter, Adam Kanack, Brian R. Curtis, Jeff Reese, Vasudeva M. Kamath, Janice G McFarland, Richard H. Aster, New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia. Transfusion. ,vol. 52, pp. 1117- 1124 ,(2012) , 10.1111/J.1537-2995.2011.03428.X
B. G. FIRKIN, R. WRIGHT, S. MILLER, E. STOKES, Splenic macrophages in thrombocytopenia. Blood. ,vol. 33, pp. 240- 245 ,(1969) , 10.1182/BLOOD.V33.2.240.240
Salley Pels, Current therapies in primary immune thrombocytopenia. Seminars in Thrombosis and Hemostasis. ,vol. 37, pp. 621- 630 ,(2011) , 10.1055/S-0031-1291372
Tsuneo FUJITA, A scanning electron microscope study of the human spleen. Archivum histologicum Japonicum. ,vol. 37, pp. 187- 216 ,(1974) , 10.1679/AOHC1950.37.187
Robert McMillan, Robert L. Longmire, Mehdi Tavassoli, Samuel Armstrong, Robert Yelenosky, In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. The New England Journal of Medicine. ,vol. 290, pp. 249- 251 ,(1974) , 10.1056/NEJM197401312900505
JAMES M. CRAWFORD, CHEN LIU, Liver and Biliary Tract Elsevier. pp. 833- 890 ,(2010) , 10.1016/B978-1-4377-0792-2.50023-7
Anne de Boisfleury, Narla Mohandas, Antibody-Induced Spherocytic Anemia II. Splenic Passage and Sequestration of Red Cells Springer, Berlin, Heidelberg. pp. 197- 205 ,(1978) , 10.1007/978-3-642-67059-6_14